Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based ...
All seven members of Arbutus Biopharma's board have resigned and been replaced by five new members, including the company's new chief executive. The virology-focused biotech company said Tuesday that ...
To McIntosh, the most surprising bankruptcy of 2024 was Eiger BioPharmaceuticals, a metabolic disease biotech that was ...
PowerUp Acquisition Corp. is a blank check company. Its objective is effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company ...
GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (“NK” ...
Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete ...
How intelligent technologies are transforming the biopharma industry’Life-changing interventions that have previously been ...
Amicus Therapeutics (NASDAQ:FOLD – Free Report) had its price objective cut by Wells Fargo & Company from $18.00 to $17.00 in ...
HC Wainwright reissued their buy rating on shares of Benitec Biopharma (NASDAQ:BNTC – Free Report) in a research report sent ...
Prolific Machines, a biotechnology innovator unlocking unprecedented cellular control with light, appoints Christina Perry as CFO.
AEON Biopharma, Inc. (NYSE: AEON) (the "Company"), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a ...